Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Veracyte (VCYT) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to 17.4%.

  • Veracyte's EBIT Margin rose 70300.0% to 17.4% in Q3 2025 from the same period last year, while for Sep 2025 it was 5.0%, marking a year-over-year increase of 105300.0%. This contributed to the annual value of 3.62% for FY2024, which is 273800.0% up from last year.
  • According to the latest figures from Q3 2025, Veracyte's EBIT Margin is 17.4%, which was up 70300.0% from 4.05% recorded in Q2 2025.
  • Veracyte's EBIT Margin's 5-year high stood at 17.4% during Q3 2025, with a 5-year trough of 123.74% in Q1 2021.
  • Moreover, its 5-year median value for EBIT Margin was 12.74% (2023), whereas its average is 16.0%.
  • In the last 5 years, Veracyte's EBIT Margin crashed by -845400bps in 2021 and then skyrocketed by 1012400bps in 2022.
  • Over the past 5 years, Veracyte's EBIT Margin (Quarter) stood at 18.32% in 2021, then surged by 63bps to 6.75% in 2022, then crashed by -436bps to 36.16% in 2023, then surged by 110bps to 3.52% in 2024, then surged by 394bps to 17.4% in 2025.
  • Its last three reported values are 17.4% in Q3 2025, 4.05% for Q2 2025, and 2.54% during Q1 2025.